DAILY EQUITY REPORT BY EPIC RESEARCH- 7 NOVEMBER 2012

download DAILY EQUITY REPORT BY EPIC RESEARCH- 7 NOVEMBER 2012

of 4

  • date post

    20-May-2015
  • Category

    Documents

  • view

    55
  • download

    1

Embed Size (px)

description

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

Transcript of DAILY EQUITY REPORT BY EPIC RESEARCH- 7 NOVEMBER 2012

  • 1. HEADLINES Indian Market Indian equity markets up by 0.35%. Nifty up by 20.2 0 pts and settle at 5724.20 Sensex up by 54.51 pts at 18817.38. Bank Nifty up by 63.90 pts at 11539.05 Global MarketDAILY EQUITY European markets were up with FTSENEWSLETTER up by 31.88 pts at 5870.94,CAC up by 26.70 pts at 3475.20 and DAX up by7TH NOVEMBER 2012 54.09 pts at 7380.56 Dow future up by 39.00pts at 13092.00 HEADLINES Central Bank Q2 net up 35% at Rs 330 cr on other income Hindalco Q2 disappoints, net profit slips 29% to Rs 359 cr Glenmark settles patent litigation with Janssen Pharma To maintain net interest margin ataround 3%: Dena BankWWW.EPICRESEARCH.CO 09752199966

2. MARKET ANALYSIS: Key benchmark indices extended gains in late trade to hit their highest level in over three weeks. The market sentiment was boosted by provisional data showing that foreign institutional investors (FIIs) remained net buyers of Indian stocks on Monday, 5 November 2012. The BSE Sensex was up 60.71 points or 0.32% to 18,823.58. The S&P CNX Nifty was up 24.95 points or 0.44% to 5,729.15. From the 30-share Sensex pack, 18 stocks gained while the rest of them fell. Britannia Industries rose 0.68% after consolidated net profit rose 36.4% to Rs 58.90 crore on 9.5%increase in revenue to Rs 1542.60 crore in Q2 September 2012 over Q2 September 2011. harma majorCipla advanced 4.09% to Rs 396 after scaling a record high of Rs 398.75 in intraday trade today, 6November 2012. After trading hours on Monday, 5 November 2012, the company said its profit aftertax jumped 61.8% to Rs 500 crore on 23.6% growth in gross revenue to Rs 2220 crore in Q2September 2012 over Q2 September 2011. STOCKS TO WATCH FIIs and DIIs HINDALCOCATEGORYDATEBUYSELLNET VIPFII 6-Nov-122502.992328.37174.62 ARVIND JP ASSOCIATEDII 6-Nov-12856.72 1078.57-221.85SCRIPS IN BAN PERIOD NIFTY DAILY PIVOTS HDILPIVOT R4 R3R2R1PP S1S2 S3S4NIFTY 5826 5789575257385715 57015678 56415604 SUZLON MC-DOWELLWWW.EPICRESEARCH.CO09752199966 3. . -GAINERS AND LOOSERS EXPERT OPINIONNIFTY DAILY NIFTY GAINERS Nifty looks SidewaysSCRIPSRATEVOL. PR.NET % Strategy: Buy on dips(000)CLOSECHANCHANGGEE Support:5670Cipla 396.859964.13 380.2016.65 4.38 Resistance: 5770Asian 138.3BANK NIFTY4095.35147.543957.003.50 Paints 5 Bank Nifty looks SidewaysACC 1473.40460.871436.5536.85 2.57 Strategy: Buy on dips AmbujaCement215.452150.59 210.055.402.57 Support:11470Ranbaxy 547.75 753.00 535.0012.75 2.38 Resistance:11610 PREVIOUS PERFORMANCE DAILY NIFTY LOOSERSTYPESCRIPB/S RESULTSCRIPS RATE VOL. PR.NET%(000)CLOSECHAN CHA NOTCASHAPTECH S EXECUTEDGE NGE TGTCASHULEX B ACHIEVED IDFC 162.55 8163.28 166.45-3.90 -2.34 TGTFUTUREPFCB RelianceACHIEVED478.75 2825.71 487.60-8.85 -1.82Infra NOTMarutiFUTUREDLFS1451.60 915.221478.25-26.65-1.80 EXECUTED Suzuki Hindalco 112.45 11028.27114.50-2.05 -1.79Tata UPCOMING RESULTS266.95 9567.83 269.80-2.85 -1.06 Motors BHARTI AIRTEL JUBILANT FOODS KINGFISHER UCO BANK ON MOBILE09752199966 4. MARKET CALLSCASHST NDSCRIPS ACTIONLEVEL1TARGET2TARGETSTOP LOSS ARVINDBUY 83.4084.2085.00 82.30 VIPSELL 78.8078.0077.00 79.60FUTURE ST NDSCRIPS ACTION LEVEL1 TARGET 2 TARGET STOP LOSS. HINDALCO SELL112.70111.70110.20 113.70 JP ASSOCIATE BUY89.3090.1091.0088.40DisclaimerThe information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept anyresponsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up onsources that we consider reliable.This material is for personal information and based upon it & takes no responsibilityThe information given herein should be treated as only factor, while making investment decision. The report does not provide individuallytailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, andencourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based onthe information given in this report, which is in violation of rules and regulations of NSE and BSE.The share price projections shown are not necessarily indicative of future price performance. The information herein, togethe r with allestimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocksrecommended. It is understood that anyone who is browsing through the site has done so at his free will and doe s not read any viewsexpressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading ofthe information is the acceptance of this disclaimer.All Rights Reserved. Investment in equity & bullion market has its own risks.We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoev er for anyfinancial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer tobuy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our callsor SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then SeriousLegal Actions can be taken.